OBJECTIVE: To describe the characteristics of patients with type 2 diabetes diagnosed before age 40 (early-onset type 2 diabetes) identified in a nation-wide, population-based study. MATERIALS AND METHODS: The survey was done in Mexico during 2006. Medical history, anthropometric and biochemical measurements were obtained in every subject. RESULTS: Cases diagnosed before (n=181) and after age 40 (n=659) were included. Early-onset type 2 diabetes was present in 13.1% of the previously diagnosed, 30.3% of the cases identified during the survey and 21.5% of the whole population with diabetes. These individuals had a greater prevalence of obesity and hypertriglyceridemia compared to the cases diagnosed after age 40. CONCLUSIONS: Early-onset type 2 diabetes was present in 21.5 % of patients with type 2 diabetes in Mexico. Close to 70% of them were obese or overweight and had the clinical profile of the metabolic syndrome.
OBJECTIVE: To describe the characteristics of patients with type 2 diabetes diagnosed before age 40 (early-onset type 2 diabetes) identified in a nation-wide, population-based study. MATERIALS AND METHODS: The survey was done in Mexico during 2006. Medical history, anthropometric and biochemical measurements were obtained in every subject. RESULTS: Cases diagnosed before (n=181) and after age 40 (n=659) were included. Early-onset type 2 diabetes was present in 13.1% of the previously diagnosed, 30.3% of the cases identified during the survey and 21.5% of the whole population with diabetes. These individuals had a greater prevalence of obesity and hypertriglyceridemia compared to the cases diagnosed after age 40. CONCLUSIONS: Early-onset type 2 diabetes was present in 21.5 % of patients with type 2 diabetes in Mexico. Close to 70% of them were obese or overweight and had the clinical profile of the metabolic syndrome.
Authors: Luis A Rodríguez; Simón Barquera; Carlos A Aguilar-Salinas; Jaime Sepúlveda-Amor; Luz María Sánchez-Romero; Edgar Denova-Gutiérrez; Nydia Balderas; Lizbeth Moreno-Loaeza; Margaret A Handley; Sanjay Basu; Oliva López-Arellano; Alberto Gallardo-Hernández; Dean Schillinger Journal: Contemp Clin Trials Date: 2020-06-21 Impact factor: 2.226
Authors: América Liliana Miranda-Lora; Jenny Vilchis-Gil; Daniel B Juárez-Comboni; Miguel Cruz; Miguel Klünder-Klünder Journal: Front Endocrinol (Lausanne) Date: 2021-03-12 Impact factor: 5.555
Authors: Omar Yaxmehen Bello-Chavolla; Armando González-Díaz; Neftali Eduardo Antonio-Villa; Carlos A Fermín-Martínez; Alejandro Márquez-Salinas; Arsenio Vargas-Vázquez; Jessica Paola Bahena-López; Carmen García-Peña; Carlos A Aguilar-Salinas; Luis Miguel Gutiérrez-Robledo Journal: J Gerontol A Biol Sci Med Sci Date: 2020-06-29 Impact factor: 6.053
Authors: Roopa Mehta; Daniel Pichel; Chih Hao Chen-Ku; Pablo Raffaele; Antonio Méndez Durán; Francisco Padilla; Jose Javier Arango Alvarez; José Esteban Costa Gil; Juan Esteban Gómez Mesa; Mariano Giorgi; Rodolfo Lahsen; Andrei C Sposito Journal: Diabetes Ther Date: 2020-12-15 Impact factor: 2.945
Authors: Marco Alberto Gamboa-Meléndez; Alicia Huerta-Chagoya; Hortensia Moreno-Macías; Paola Vázquez-Cárdenas; María Luisa Ordóñez-Sánchez; Rosario Rodríguez-Guillén; Laura Riba; Maribel Rodríguez-Torres; María Teresa Guerra-García; Luz Elizabeth Guillén-Pineda; Shweta Choudhry; Laura Del Bosque-Plata; Samuel Canizales-Quinteros; Gustavo Pérez-Ortiz; Fernando Escobedo-Aguirre; Adalberto Parra; Israel Lerman-Garber; Carlos Alberto Aguilar-Salinas; María Teresa Tusié-Luna Journal: Diabetes Date: 2012-08-24 Impact factor: 9.461
Authors: Simon Barquera; Ismael Campos-Nonato; Carlos Aguilar-Salinas; Ruy Lopez-Ridaura; Armando Arredondo; Juan Rivera-Dommarco Journal: Global Health Date: 2013-02-02 Impact factor: 4.185